EP 1028719 A1 20000823 - TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER AND NARCOLEPSY
Title (en)
TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER AND NARCOLEPSY
Title (de)
BEHANDLUNG VON HYPERAKTIVITÄT MIT AUFMERKSAMKEITSTÖRUNGEN UND SCHLAFKRANKHEIT
Title (fr)
TRAITEMENT DE L'HYPERACTIVITE INDUITE PAR LES TROUBLES D'ATTENTION ET DE LA NARCOLEPSIE
Publication
Application
Priority
- GB 9802124 W 19980717
- GB 9715082 A 19970717
Abstract (en)
[origin: WO9903458A1] This invention relates to the use of a pharmaceutical composition for oral administration comprising a carrier and, as an active ingredient, a monoamine oxidase B inhibitor, characterised in that the composition is formulated to promote pre-gastric absorption of said monoamine oxidase B inhibitor, for the manufacture of a medicament for the treatment of Attention Deficit Hyperactivity Disorder and/or narcolepsy. A method of treating Attention Deficit Hyperactivity Disorder and/or narcolepsy is also provided.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/00 (2006.01); A61K 31/131 (2006.01); A61K 31/135 (2006.01); A61K 31/137 (2006.01); A61K 31/44 (2006.01)
CPC (source: EP)
A61K 9/0056 (2013.01); A61K 9/2095 (2013.01); A61K 31/00 (2013.01); A61K 31/131 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/44 (2013.01)
Citation (search report)
See references of WO 9903458A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9903458 A1 19990128; AU 1645699 A 19990222; EP 1028719 A1 20000823; GB 9715082 D0 19970924
DOCDB simple family (application)
GB 9802124 W 19980717; AU 1645699 A 19980717; EP 98967116 A 19980717; GB 9715082 A 19970717